DO NOT PRESCRIBE (DNP): NICE TA240: Colorectal cancer metastatic. Unable to recommend NHS use - TA terminated due to lack of evidence submission (decision date - January 2012)
DO NOT PRESCRIBE (DNP): NICE TA242: Colorectal cancer (metastatic) 2nd line. Panitumumab – not recommended (decision date - February 2012)
RED 1,2,3 : NICE TA439 - cetuximab and panitumumab for previously untreated metastatic colorectal cancer. (decision date - May 2017)
(This drug can be funded through the cancer drug fund - seek advice from the oncologist/haematologist)